• AI tools are going to “start generating much more patient-specific insights,” former FDA commissioner Scott Gottlieb said. “And that’s really the future.”

The big picture: The holy grail of cancer treatment is precision medicine — care tailored to a patient’s unique manifestation of the disease.

• Getting there requires better insight into each patient’s cancer, more sophisticated tools to help match it to the right treatment, and the ability to do that work at scale — and at a price patients and insurance companies can handle.
• All that is happening, or at least getting closer.